Gut microbial signatures and immunotherapy outcomes in NSCLC and melanoma: a systematic review and meta-analysis
Abstract Background The composition of the gut microbiome has been linked to clinical responses to immune checkpoint inhibitors (ICIs), but its prognostic association with outcomes in non-small cell lung cancer (NSCLC) and melanoma remains incompletely defined. We performed a systematic review and m...
שמור ב:
| Principais autores: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMC
2026-02-01
|
| סדרה: | BMC Cancer |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1186/s12885-026-15763-3 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
